Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 79, Issue 6, 2008, Pages 215-222

  Shearer, Gregory C ^a,b   Newman, John W ^b,c  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Eicosanoid; Hyperlipidemia; Lipoprotein lipase; LpL; Metabolic profiling; Octadecanoid; Oxylipid; Oxylipin; VLDL

Indexed keywords

ALCOHOL DERIVATIVE; ARACHIDONIC ACID; EPOXIDE; KETONE DERIVATIVE; LINOLEIC ACID; LIPOPROTEIN LIPASE; OXYLIPIN; POLYUNSATURATED FATTY ACID; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; ESTERIFICATION; FEMALE; HYDROLYSIS; HYPERLIPIDEMIA; LIPOLYSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT;

ANIMALS; FEMALE; LIPOLYSIS; LIPOPROTEIN LIPASE; LIPOPROTEINS, VLDL; MOLECULAR STRUCTURE; OXYLIPINS; RATS; RATS, ZUCKER;

RATTUS;

EID: 61349180710     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2008.09.023     Document Type: Article

References (39)

1. Murphy R.C., Khaselev N., Nakamura T., and Hall L.M. Oxidation of glycerophospholipids from biological membranes by reactive oxygen species: liquid chromatographic-mass spectrometric analysis of eicosanoid products. J. Chromatogr. B Biomed. Sci. Appl. 731 (1999) 59-71
2. Newman J.W., Kaysen G.A., Hammock B.D., and Shearer G.C. Proteinuria increases oxylipid concentrations in VLDL and HDL, but not LDL particles in the rat. J. Lipid Res. (2007)
3. Shearer G.C., Stevenson F.T., Atkinson D.N., Jones H., Staprans I., and Kaysen G.A. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome. Kidney Int. 59 (2001) 179-189
4. Shearer G.C., and Kaysen G.A. Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion. Kidney Int. 70 (2006) 647-653
5. Ahmed W., Orasanu G., Nehra V., et al. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ. Res. 98 (2006) 490-498
6. Ziouzenkova O., and Plutzky J. Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?. Curr. Opin. Clin. Nutr. Metab. Care 7 (2004) 369-375
7. Schumaker V.N., and Puppione D.L. Sequential flotation ultracentrifugation. Method. Enzymol. 128 (1986) 155-170
8. Benjaminit Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57 (1995) 289-300
9. Akiba S., Ii H., Yoneda Y., and Sato T. Translocation of phospholipase A2 to membranes by oxidized LDL and hydroxyoctadecadienoic acid to contribute to cholesteryl ester formation. Biochim. Biophys. Acta 1686 (2004) 77-84
10. Obinata H., Hattori T., Nakane S., Tatei K., and Izumi T. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J. Biol. Chem. 280 (2005) 40676-40683
11. Muller C., Friedrichs B., Wingler K., and Brigelius-Flohe R. Perturbation of lipid metabolism by linoleic acid hydroperoxide in CaCo-2 cells. Biol. Chem. 383 (2002) 637-648
12. Folcik V.A., and Cathcart M.K. Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL. J. Lipid Res. 35 (1994) 1570-1582
13. Ku G., Thomas C.E., Akeson A.L., and Jackson R.L. Induction of interleukin 1 beta expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid. J. Biol. Chem. 267 (1992) 14183-14188
14. Folcik V.A., Nivar-Aristy R.A., Krajewski L.P., and Cathcart M.K. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96 (1995) 504-510
15. Karara A., Wei S., Spady D., Swift L., Capdevila J.H., and Falck J.R. Arachidonic acid epoxygenase: structural characterization and quantification of epoxyeicosatrienoates in plasma. Biochem. Biophys. Res. Commun. 182 (1992) 1320-1325
16. Keiper T., Schneider J.G., and Dugi K.A. Novel site in lipoprotein lipase (LPL415;-438) essential for substrate interaction and dimer stability. J. Lipid Res. 42 (2001) 1180-1186
17. Newman J.W., Watanabe T., and Hammock B.D. The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by high-performance liquid chromatography-tandem mass spectroscopy. J. Lipid Res. 43 (2002) 1563-1578
18. Morrow J.D., Awad J.A., Boss H.J., Blair I.A., and Roberts II L.J. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA 89 (1992) 10721-10725
19. Arneson K.O., and Roberts II L.J. Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans. Method. Enzymol. 433 (2007) 127-143
20. Raz A. Interaction of prostaglandins with blood plasma proteins. I. Binding of prostaglandin E 2 to human plasma proteins and its effect on the physiological activity of prostaglandin E 2 in vitro and in vivo. Biochim. Biophys. Acta 280 (1972) 602-613
21. Raz A. Interaction of prostaglandins with blood plasma proteins. Comparative binding of prostaglandins A 2, F 2 and E 2 to human plasma proteins. Biochem. J. 130 (1972) 631-636
22. Raz A. Interaction of prostaglandins with blood plasma proteins. 3. Rate of disappearance and metabolites formation after intravenous administration of free or albumin-bound prostaglandins F 2 and A 2. Life Sci. II 11 (1972) 965-974
23. Maclouf J., Kindahl H., Granstrom E., and Samuelsson B. Interactions of prostaglandin H2 and thromboxane A2 with human serum albumin. Eur. J. Biochem. 109 (1980) 561-566
24. O'Brien W.F., Torres C., Benoit R., and Knuppel R.A. The association between apolipoprotein A-I and prostacyclin binding in human serum. Prostaglandins 38 (1989) 45-51
25. Pietzsch J., Wiedemann B., Julius U., et al. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. J. Lipid Res. 37 (1996) 2074-2087
26. Stafforini D.M., Sheller J.R., Blackwell T.S., et al. Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases. J. Biol. Chem. 281 (2006) 4616-4623
27. Schmelzer K.R., Kubala L., Newman J.W., Kim I.H., Eiserich J.P., and Hammock B.D. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc. Natl. Acad. Sci. USA 102 (2005) 9772-9777
28. Shashkin P.N., Jain N., Miller Y.I., et al. Insulin and glucose play a role in foam cell formation and function. Cardiovasc. Diabetol. 5 (2006) 13
29. Sasson S., and Eckel J. Disparate effects of 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid in vascular endothelial and smooth muscle cells and in cardiomyocytes. Arch. Physiol. Biochem. 112 (2006) 119-129
30. Natarajan R., and Nadler J.L. Lipid inflammatory mediators in diabetic vascular disease. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1542-1548
31. Shishehbor M.H., Zhang R., Medina H., et al. Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radic. Biol. Med. 41 (2006) 1678-1683
32. Larsen B.T., Campbell W.B., and Gutterman D.D. Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system. Trends Pharmacol. Sci. 28 (2007) 32-38
33. Xu D., Li N., He Y., et al. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc. Natl. Acad. Sci. USA 103 (2006) 18733-18738
34. Seubert J., Yang B., Bradbury J.A., et al. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ. Res. 95 (2004) 506-514
35. Stamatiou P., Hamid Q., Taha R., et al. 5-Oxo-ETE induces pulmonary eosinophilia in an integrin-dependent manner in Brown Norway rats. J. Clin. Invest. 102 (1998) 2165-2172
36. Muro S., Hamid Q., Olivenstein R., Taha R., Rokach J., and Powell W.S. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin. J. Allergy Clin. Immunol. 112 (2003) 768-774
37. Imig J.D. Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am. J. Physiol. Renal Physiol. 289 (2005) F496-F503
38. Altmann R., Hausmann M., Spottl T., et al. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells. Biochem. Pharmacol. 74 (2007) 612-622
39. Milne G.L., Seal J.R., Havrilla C.M., Wijtmans M., and Porter N.A. Identification and analysis of products formed from phospholipids in the free radical oxidation of human low density lipoproteins. J. Lipid Res. 46 (2005) 307-319